Foyston Gordon & Payne Inc Sells 1,455 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Foyston Gordon & Payne Inc lowered its stake in UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 3.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 43,494 shares of the healthcare conglomerate’s stock after selling 1,455 shares during the period. UnitedHealth Group makes up approximately 5.1% of Foyston Gordon & Payne Inc’s portfolio, making the stock its 4th biggest holding. Foyston Gordon & Payne Inc’s holdings in UnitedHealth Group were worth $21,840,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in UNH. Assetmark Inc. boosted its stake in shares of UnitedHealth Group by 5.2% in the third quarter. Assetmark Inc. now owns 213,353 shares of the healthcare conglomerate’s stock valued at $83,366,000 after buying an additional 10,463 shares in the last quarter. Lincoln National Corp boosted its position in UnitedHealth Group by 15.1% during the fourth quarter. Lincoln National Corp now owns 8,951 shares of the healthcare conglomerate’s stock worth $4,495,000 after purchasing an additional 1,174 shares in the last quarter. Dohj LLC boosted its position in UnitedHealth Group by 4.2% during the third quarter. Dohj LLC now owns 6,446 shares of the healthcare conglomerate’s stock worth $2,968,000 after purchasing an additional 257 shares in the last quarter. YorkBridge Wealth Partners LLC lifted its position in shares of UnitedHealth Group by 1.8% in the fourth quarter. YorkBridge Wealth Partners LLC now owns 15,296 shares of the healthcare conglomerate’s stock valued at $7,681,000 after acquiring an additional 272 shares in the last quarter. Finally, Alexandria Capital LLC lifted its position in shares of UnitedHealth Group by 3.5% in the third quarter. Alexandria Capital LLC now owns 17,100 shares of the healthcare conglomerate’s stock valued at $6,682,000 after acquiring an additional 584 shares in the last quarter. 87.48% of the stock is currently owned by institutional investors and hedge funds.

UNH stock traded up $7.17 during trading hours on Thursday, reaching $478.55. The stock had a trading volume of 3,812,571 shares, compared to its average volume of 3,347,439. The company has a debt-to-equity ratio of 0.54, a current ratio of 0.78 and a quick ratio of 0.78. The stock has a 50-day simple moving average of $511.16 and a 200 day simple moving average of $485.04. The stock has a market capitalization of $448.96 billion, a PE ratio of 25.99, a price-to-earnings-growth ratio of 1.52 and a beta of 0.83. UnitedHealth Group Incorporated has a fifty-two week low of $383.12 and a fifty-two week high of $553.29.

UnitedHealth Group (NYSE:UNHGet Rating) last announced its quarterly earnings results on Thursday, April 14th. The healthcare conglomerate reported $5.49 earnings per share for the quarter, topping analysts’ consensus estimates of $5.40 by $0.09. UnitedHealth Group had a return on equity of 24.74% and a net margin of 5.86%. The firm had revenue of $80.15 billion for the quarter, compared to the consensus estimate of $78.77 billion. During the same quarter in the previous year, the business earned $5.31 earnings per share. The business’s revenue was up 14.2% compared to the same quarter last year. On average, sell-side analysts forecast that UnitedHealth Group Incorporated will post 21.75 EPS for the current fiscal year.

Several equities analysts recently commented on the company. Raymond James upped their target price on UnitedHealth Group from $540.00 to $620.00 and gave the company a “strong-buy” rating in a research note on Tuesday, April 19th. Cowen upped their target price on UnitedHealth Group from $512.00 to $596.00 in a research note on Monday, April 18th. BMO Capital Markets raised their price objective on UnitedHealth Group from $510.00 to $600.00 and gave the stock a “market perform” rating in a report on Tuesday, April 19th. StockNews.com began coverage on shares of UnitedHealth Group in a research note on Thursday, March 31st. They set a “strong-buy” rating for the company. Finally, SVB Leerink upped their target price on shares of UnitedHealth Group from $550.00 to $600.00 and gave the company an “outperform” rating in a research note on Tuesday, April 19th. Two investment analysts have rated the stock with a hold rating, twenty have issued a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group currently has an average rating of “Buy” and a consensus target price of $550.17.

In related news, Director Richard T. Burke sold 4,000 shares of the company’s stock in a transaction dated Tuesday, March 22nd. The shares were sold at an average price of $511.14, for a total value of $2,044,560.00. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Richard T. Burke sold 6,000 shares of the stock in a transaction that occurred on Friday, February 25th. The stock was sold at an average price of $470.38, for a total value of $2,822,280.00. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 15,500 shares of company stock valued at $7,626,365. Company insiders own 0.55% of the company’s stock.

UnitedHealth Group Company Profile (Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Featured Stories

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.